Daniel Elenius Madsen

Daniel Elenius Madsen serves as the Head of Toxicology and Clinical Pharmacology and Principal Development Pharmacologist at LEO Pharma since November 2018. Madsen's extensive experience includes roles as a Senior Clinical Pharmacologist in Global R&D and mentoring at Synapse - Life Science Connect from July 2017 to September 2020. Previously, Madsen worked at Novo Nordisk from September 2014 to November 2018 as a Senior Research Scientist and Talent Ambassador, with a focus on translational haemophilia pharmacology and project management. Madsen's academic background includes a PhD from the University of Southern Denmark, where research centered on C1-inh polymers in hereditary angioedema, along with previous positions at prestigious institutions such as UMC Utrecht and University Medical Center Utrecht. Madsen holds a Master of Science degree in Biomedicine from Syddansk Universitet.